MEDTRONIC HEART VALVES DIVISION MOSAIC MITRAL BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE
|
Back to Search Results |
|
Model Number 310C |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Corneal Pannus (1447); Abscess (1690); Endocarditis (1834); Sepsis (2067); Thrombus (2101); Tricuspid Regurgitation (2112); Complete Heart Block (2627)
|
Event Date 04/13/2015 |
Event Type
Injury
|
Manufacturer Narrative
|
The device was discarded by the customer, therefore no product analysis can be performed.Without return of the product, no definitive conclusions can be drawn regarding the clinical observation.Should additional information become available, a supplemental report will be submitted.(b)(4).
|
|
Event Description
|
Medtronic received information that a non-medtronic permanent pacemaker was implanted for complete heart block following the implant of this 29mm bioprosthetic valve in the tricuspid position.Two months post implant, the patient had recurrent endocarditis and sepsis involving the valve, permanent pacemaker, and leads.Four months post implant, the valve, pacemaker, and pacing leads were replaced due to vegetation on the valve, pannus, thrombus, a periannular abscess, and regurgitation.The valve was replaced with a 27mm valve of the same model.No other adverse patient effects were reported.
|
|
Manufacturer Narrative
|
Conclusion: a review of the device history record (dhr) for this valve was performed, there was no issue identified regarding manufacturing and sterilization (raw materials, manufacturing time period, packaging and labelling, or sterilization load) that would have impacted this event.Cardiac dysrhythmias (i.E.Heart block) are known potential adverse events per mosaic instructions for use (ifu).These issues can be resolved with the implant of a permanent pacemaker.Without the return of the valve, root causes for the endocarditis and regurgitation were unable to be determined.However, based on the operative report, the patient had a history of intravenous (iv) drug abuse and a history of previous endocarditis; this clinical history indicates that the reoccurring endocarditis could be potentially due to a patient-related condition.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|